HER2-Targeted Hybrid Peptide That Blocks HER2 Tyrosine Kinase Disintegrates Cancer Cell Membrane and Inhibits Tumor Growth in Vivo
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-12-0357
Full Text
Open PDFAbstract
Available in full text
Date
January 28, 2013
Authors
Publisher
American Association for Cancer Research (AACR)